Form 8-K Valeant Pharmaceuticals For: Apr 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/13/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Valeant Pharma (VRX) Details Compensation for Incoming CEO Papa, Outgoing CEO Pearson
April 28, 2016 6:21 AM EDTValeant Pharma (NYSE: VRX) disclosed teh following late Thursday:
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Joseph C. Papa -- New Chairman and CEO
On April 25, 2016, the Board of Directors (the Board) of Valeant Pharmaceuticals International, Inc. (Valeant or the Company) announced the appointment of Joseph C. Papa to become Valeants Chairman and Chief Executive Officer. Mr. Papa, is expected to join the Company by early May and will succeed J.... More
